Neoadjuvant SBRT combined with immunotherapy in NSCLC: from mechanisms to therapy

The utilisation of neoadjuvant immunotherapy has demonstrated promising preliminary clinical outcomes for early-stage resectable non-small-cell lung cancer (NSCLC). Nevertheless, it is imperative to develop novel neoadjuvant combination therapy regimens incorporating immunotherapy to further enhance...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Yanhong, Ma, Xiaoyan, He, Dan, Dong, Bingwei, Qiao, Tianyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435737/
https://www.ncbi.nlm.nih.gov/pubmed/37600799
http://dx.doi.org/10.3389/fimmu.2023.1213222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435737/
https://www.ncbi.nlm.nih.gov/pubmed/37600799
http://dx.doi.org/10.3389/fimmu.2023.1213222

Ejemplares similares